Want to hire this expert for a project? Request a quote for free.
USD 45 /hr
Hire Dr. Anke V.
USD 45 /hr
Biomedical Science PhD with 4+ years experience in preclinical, translational (pediatric) oncology.
Subject Matter Expertise
Writing Clinical Trial Documentation, Technical Writing
Research Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection
Data & AI Statistical Analysis, Data Visualization
Charles River Laboratories
February 2020 - Present
January 2019 - Present
April 2015 - December 2018
January 2014 - July 2014
June 2013 - December 2013
Radboud Universiteit Nijmegen Radboud Institute for Molecular Life Sciences
May 2012 - July 2012
September 2012 - August 2014
September 2009 - August 2012
- Certification details not provided.
(2020). Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo . Journal of Cancer Research and Clinical Oncology.
(2018). Targeted Therapy-based Combination Treatment in Rhabdomyosarcoma . Molecular Cancer Therapeutics.
(2017). Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma with the Second-Generation ALK Inhibitor Ceritinib . Targeted Oncology.
(2017). Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent . Oncotarget.
(2017). Phosphoproteomic profiling reveals ALK and MET as novel actionable targets across synovial sarcoma subtypes. Cancer Research.
van Erp, Anke, Hassan, Hisham Y, Jaeger, Martin, Tahir, Hanan, Oosting, Marije, Joosten, Leo A B, Netea, Mihai G(2016). Genetic diversity of lactase persistence in East African populations . BMC research notes. 9. (1). p. 8.